Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 209210

BYDUREON BCISE (EXENATIDE)
2MG/0.85ML (2MG/0.85ML) Marketing Status: Prescription

Active Ingredient: EXENATIDE
Proprietary Name: BYDUREON BCISE
Dosage Form; Route of Administration: SUSPENSION, EXTENDED RELEASE; SUBCUTANEOUS
Strength: 2MG/0.85ML (2MG/0.85ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N209210
Product Number: 001
Approval Date: Oct 20, 2017
Applicant Holder Full Name: ASTRAZENECA AB
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English